https://biotechmorning.com/news/sanofi-eu-antitrust-flu-vaccine-marketing Biotech Morning en 2026-07-16T14:25:56.699Z Sanofi Got Caught Trash-Talking a Rival Vaccine https://biotechmorning.com/news/novartis-myricx-bio-adc-acquisition-2 Biotech Morning en 2026-07-16T14:25:06.309Z Novartis Just Paid $1.1 Billion for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/abbvie-apogee-therapeutics-acquisition Biotech Morning en 2026-07-16T14:24:13.770Z AbbVie Just Bet $10.9 Billion on One Molecule. Here's Why. https://biotechmorning.com/news/sobi-gout-drug-fda-manufacturing-rejection Biotech Morning en 2026-07-16T14:23:17.347Z Sobi's Gout Drug Aced Every Test. The FDA Still Said No. https://biotechmorning.com/news/pfizer-penicillin-recall-syphilis-pregnancy-crisis Biotech Morning en 2026-07-16T14:22:24.727Z The One Drug That Stops Babies From Going Blind Just Got Recalled https://biotechmorning.com/news/generic-ozempic-south-africa-sun-pharma Biotech Morning en 2026-07-16T14:21:33.137Z Novo Nordisk's Worst Nightmare Just Landed in South Africa https://biotechmorning.com/news/eye-gene-therapy-easy-win-jnj Biotech Morning en 2026-07-16T14:20:43.000Z The Eye Was Supposed to Be Gene Therapy's Easy Win https://biotechmorning.com/news/fda-approves-first-treg-cell-therapy-tregzi Biotech Morning en 2026-07-16T14:19:41.623Z The FDA Just Created a Whole New Category of Cell Therapy https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-duchenne-2 Biotech Morning en 2026-07-16T14:18:53.437Z Sarepta's Worst Week: Two Deaths, a Black Box, and 500 Pink Slips https://biotechmorning.com/news/oral-wegovy-pill-eu-approval-obesity Biotech Morning en 2026-07-16T14:17:54.450Z The Weight-Loss Pill That Could Replace Your Weekly Injection https://biotechmorning.com/news/ebola-pill-obeldesivir-trial-congo-outbreak Biotech Morning en 2026-07-15T14:27:16.832Z An Ebola Pill Gets Its First Real Test in the Middle of an Outbreak https://biotechmorning.com/news/insilico-bora-ai-drug-manufacturing-partnership Biotech Morning en 2026-07-15T14:26:21.188Z The $2.5 Billion Handshake That Could Rewrite How Drugs Get Made https://biotechmorning.com/news/biogen-diranersen-alzheimers-phase-2-tau-phase-3 Biotech Morning en 2026-07-15T14:25:27.744Z Biogen's Alzheimer's Drug Failed Its Test. They're Betting Billions Anyway. https://biotechmorning.com/news/celcuity-gedatolisib-fda-approval-breast-cancer Biotech Morning en 2026-07-15T14:24:37.795Z The $10 Million Drug That Just Turned Celcuity Into a $5 Billion Company https://biotechmorning.com/news/attovia-ipo-dupixent-challenger Biotech Morning en 2026-07-15T14:23:39.977Z The Bet to Dethrone Immunology's Biggest Cash Cow https://biotechmorning.com/news/fda-distributed-manufacturing-biologics-framework Biotech Morning en 2026-07-15T14:22:47.006Z The FDA Wants to Build Drug Factories Inside Hospitals https://biotechmorning.com/news/fda-final-guidance-psychedelic-clinical-trials Biotech Morning en 2026-07-15T14:21:53.735Z The FDA Just Wrote a Rulebook for Tripping